Notify me when BVF INC/IL files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 41 | $2,970,708,839 | +$260,536,959 | -$644,965,279 | -$384,428,320 | KYMR, RVMD, MLTX, GPCR, OLMA | 13F-HR | 17 Feb 2026, 16:03 |
| Q3 2025 | 46 | $2,466,911,543 | +$360,328,606 | -$598,951,599 | -$238,622,993 | KYMR, RVMD, PTGX, MLTX, CDTX | 13F-HR | 14 Nov 2025, 16:00 |
| Q2 2025 | 44 | $2,799,144,005 | +$119,962,000 | -$142,810,249 | -$22,848,249 | MLTX, KYMR, RVMD, PTGX, AXSM | 13F-HR | 14 Aug 2025, 16:01 |
| Q1 2025 | 51 | $2,453,567,172 | +$236,560,212 | -$123,251,764 | +$113,308,448 | MLTX, AXSM, RVMD, KYMR, MIRM | 13F-HR | 15 May 2025, 16:01 |
| Q4 2024 | 53 | $2,950,707,648 | +$274,350,807 | -$422,676,780 | -$148,325,973 | MLTX, KYMR, RVMD, AXSM, MIRM | 13F-HR | 14 Feb 2025, 16:00 |
| Q3 2024 | 55 | $3,418,343,431 | +$89,104,119 | -$558,953,673 | -$469,849,554 | MLTX, KYMR, RVMD, MIRM, TYRA | 13F-HR | 14 Nov 2024, 16:00 |
| Q2 2024 | 60 | $3,567,995,778 | +$442,096,922 | -$216,061,851 | +$226,035,071 | MLTX, RVMD, KYMR, IONS, MIRM | 13F-HR | 14 Aug 2024, 16:10 |
| Q1 2024 | 62 | $3,637,401,571 | +$143,367,668 | -$746,761,948 | -$603,394,280 | MLTX, KYMR, RVMD, FDMT, GHRS | 13F-HR | 15 May 2024, 16:01 |
| Q4 2023 | 70 | $3,995,809,154 | +$311,954,137 | -$467,534,485 | -$155,580,348 | MLTX, RVMD, AXSM, PTGX, KYMR | 13F-HR | 14 Feb 2024, 16:02 |
| Q3 2023 | 69 | $3,708,416,589 | +$351,509,249 | -$108,003,988 | +$243,505,261 | MLTX, IONS, AXSM, IDYA, MIRM | 13F-HR | 14 Nov 2023, 16:00 |
| Q2 2023 | 67 | $3,587,844,306 | +$213,510,718 | -$237,102,693 | -$23,591,975 | MLTX, RVMD, AXSM, IDYA, IONS | 13F-HR | 14 Aug 2023, 16:01 |
| Q1 2023 | 72 | $2,735,588,523 | +$493,571,214 | -$196,972,244 | +$296,598,970 | MLTX, KYMR, AXSM, RVMD, IONS | 13F-HR | 15 May 2023, 16:00 |
| Q4 2022 | 78 | $2,369,483,196 | +$331,893,867 | -$391,117,393 | -$59,223,526 | MLTX, AXSM, RPTX, KYMR, GHRS | 13F-HR | 14 Feb 2023, 16:00 |
| Q3 2022 | 80 | $2,417,097,000 | +$303,335,025 | -$153,209,713 | +$150,125,312 | MLTX, IONS, GHRS, KYMR, RPTX | 13F-HR | 14 Nov 2022, 16:05 |
| Q2 2022 | 79 | $2,070,615,000 | +$386,267,848 | -$256,128,288 | +$130,139,560 | RPTX, MLTX, RCUS, CGEM, GHRS | 13F-HR | 15 Aug 2022, 16:45 |
| Q1 2022 | 81 | $2,499,885,000 | +$457,567,329 | -$175,832,880 | +$281,734,449 | GHRS, KYMR, RLAY, RCUS, MRUS | 13F-HR | 16 May 2022, 16:15 |
| Q4 2021 | 83 | $2,755,083,000 | +$636,327,886 | -$237,984,799 | +$398,343,087 | GHRS, KYMR, RCUS, MRUS, PTGX | 13F-HR | 14 Feb 2022, 16:01 |
| Q3 2021 | 75 | $2,563,130,000 | +$505,361,555 | -$387,273,246 | +$118,088,309 | GHRS, KYMR, OLMA, RCUS, MERUS N V | 13F-HR | 15 Nov 2021, 16:03 |
| Q2 2021 | 70 | $2,668,191,000 | +$603,851,367 | -$518,546,536 | +$85,304,831 | GHRS, ARGX, OLMA, PTGX, MRUS | 13F-HR | 16 Aug 2021, 16:23 |
| Q1 2021 | 67 | $2,667,271,000 | +$610,986,601 | -$526,915,397 | +$84,071,204 | FPRX, OLMA, MRUS, XOMA, RVMD | 13F-HR | 17 May 2021, 16:03 |
| Q4 2020 | 68 | $2,541,924,000 | +$704,024,227 | -$659,510,697 | +$44,513,530 | OLMA, XOMA, KYMR, RLAY, RVMD | 13F-HR | 12 Feb 2021, 16:03 |
| Q3 2020 | 62 | $1,836,113,000 | +$528,016,219 | -$302,706,374 | +$225,309,845 | RLAY, SWTX, RPTX, KYMR, XNCR | 13F-HR | 13 Nov 2020, 09:45 |
| Q2 2020 | 57 | $1,621,949,000 | +$477,648,249 | -$234,547,686 | +$243,100,563 | SWTX, PRNB, ARGX, IONS, MRUS | 13F-HR | 14 Aug 2020, 15:06 |
| Q1 2020 | 57 | $1,072,904,000 | +$178,650,296 | -$221,550,451 | -$42,900,155 | PRNB, IONS, ACIU, SWTX, XOMA | 13F-HR | 15 May 2020, 15:30 |
| Q4 2019 | 57 | $1,318,974,000 | +$372,659,257 | -$250,397,983 | +$122,261,274 | IONS, SWTX, ACIU, PRNB, CYTK | 13F-HR | 14 Feb 2020, 16:43 |
| Q3 2019 | 59 | $951,786,000 | +$269,520,939 | -$140,081,980 | +$129,438,959 | MRUS, SWTX, IONS, ACIU, CYTK | 13F-HR | 14 Nov 2019, 15:47 |
| Q2 2019 | 56 | $915,607,000 | +$159,473,921 | -$233,069,187 | -$73,595,266 | MRUS, CYTK, ARRY, ACIU, MRTX | 13F-HR | 14 Aug 2019, 15:00 |
| Q1 2019 | 53 | $893,065,000 | +$99,826,960 | -$199,447,346 | -$99,620,386 | ARRY, MRUS, BPMC, KURA, FPRX | 13F-HR | 15 May 2019, 16:00 |
| Q4 2018 | 55 | $765,187,000 | +$82,139,070 | -$117,359,622 | -$35,220,552 | CCXI, ARRY, MRUS, KURA, BPMC | 13F-HR | 14 Feb 2019, 13:31 |
| Q3 2018 | 57 | $1,137,993,000 | +$191,920,354 | -$61,218,338 | +$130,702,016 | ARRY, CCXI, MRUS, CYTK, FPRX | 13F-HR | 14 Nov 2018, 16:21 |
| Q2 2018 | 51 | $1,024,616,000 | +$218,406,967 | -$194,804,772 | +$23,602,195 | CCXI, MRUS, ARRY, CYTK, ARQL | 13F-HR | 14 Aug 2018, 13:41 |
| Q1 2018 | 43 | $986,483,000 | +$237,203,958 | -$187,678,474 | +$49,525,484 | CCXI, IRWD, ARRY, BPMC, ARQL | 13F-HR | 07 May 2018, 17:16 |
| Q4 2017 | 43 | $829,549,000 | +$210,001,900 | -$324,249,025 | -$114,247,125 | ARRY, ANAB, BPMC, XOMA, CNCE | 13F-HR | 14 Feb 2018, 15:08 |
| Q3 2017 | 37 | $786,726,000 | +$197,057,712 | -$144,406,637 | +$52,651,075 | ARRY, BPMC, CCXI, ANAB, CNCE | 13F-HR | 14 Nov 2017, 14:40 |
| Q2 2017 | 34 | $643,978,000 | +$125,467,472 | -$80,825,577 | +$44,641,895 | BPMC, CCXI, ARRY, ANAB, LOXO | 13F-HR | 14 Aug 2017, 14:50 |
| Q1 2017 | 30 | $587,934,000 | +$137,692,444 | -$140,672,767 | -$2,980,323 | BPMC, CCXI, CYTK, ANAB, CNCE | 13F-HR | 15 May 2017, 15:26 |
| Q4 2016 | 29 | $497,725,000 | +$70,082,901 | -$94,768,226 | -$24,685,325 | BPMC, CYTK, CCXI, ARRY, CNCE | 13F-HR | 14 Feb 2017, 15:13 |
| Q3 2016 | 29 | $530,675,000 | +$72,242,077 | -$140,313,441 | -$68,071,364 | BPMC, CCXI, CYTK, ARRY, CASC | 13F-HR | 14 Nov 2016, 17:24 |
| Q2 2016 | 34 | $469,389,000 | +$98,886,711 | -$78,612,859 | +$20,273,852 | BPMC, CYTK, CCXI, EXELIXIS INC, CNCE | 13F-HR | 15 Aug 2016, 16:39 |
| Q1 2016 | 32 | $404,119,000 | +$67,772,039 | -$42,819,253 | +$24,952,786 | BPMC, CNCE, CYTK, FWP, ONTY | 13F-HR | 16 May 2016, 16:02 |
| Q4 2015 | 30 | $586,783,000 | +$124,067,627 | -$93,611,465 | +$30,456,162 | BPMC, CCXI, CTIC, CNCE, ONTY | 13F-HR | 16 Feb 2016, 15:36 |
| Q3 2015 | 27 | $495,010,000 | +$92,278,350 | -$72,962,428 | +$19,315,922 | IRWD, CCXI, ONTY, ARRY, CNCE | 13F-HR | 16 Nov 2015, 16:54 |
| Q2 2015 | 30 | $566,566,000 | +$118,798,850 | -$86,483,157 | +$32,315,693 | ARRY, CCXI, BPMC, FWP, CNCE | 13F-HR | 14 Aug 2015, 17:00 |
| Q1 2015 | 30 | $478,239,000 | +$28,342,126 | -$141,415,727 | -$113,073,601 | ARRY, CCXI, IRWD, FWP, OMED | 13F-HR | 15 May 2015, 16:22 |
| Q4 2014 | 31 | $514,075,000 | +$92,204,578 | -$152,836,770 | -$60,632,192 | IRWD, CCXI, ARRY, LGND, OMED | 13F-HR | 17 Feb 2015, 16:27 |
| Q3 2014 | 32 | $481,628,000 | +$81,715,058 | -$103,884,648 | -$22,169,590 | IRWD, RCPT, LGND, ARRY, CCXI | 13F-HR | 14 Nov 2014, 16:15 |
| Q2 2014 | 29 | $632,347,000 | +$87,049,412 | -$34,941,338 | +$52,108,074 | IRWD, LGND, ARRY, CCXI, RCPT | 13F-HR | 14 Aug 2014, 16:15 |
| Q1 2014 | 27 | $600,053,000 | +$39,138,812 | -$103,734,291 | -$64,595,479 | LGND, IRWD, CCXI, ARRY, OMED | 13F-HR | 15 May 2014, 17:05 |
| Q4 2013 | 26 | $571,525,000 | $0 | $0 | $0 | LGND, IRWD, EXELIXIS INC, CCXI, ARRY | 13F-HR | 14 Feb 2014, 16:39 |